German company fights hepatitis E in Namibia
blueplanet Investments AG provides innovative, ecological solutions for treatment of up to 77 million liters of water
Frankfurt, 17 September 2019 – Namibia has reported more than 6,000 suspected cases of hepatitis E in the last 20 months. The German company blueplanet Investments AG is now taking up the fight against the potentially fatal disease in the African country and is providing two affected settlements with a new solution for water treatment and disinfection free of charge. The first step was taken at beginning of September when the technology was handed over to a clinic of the DRC settlement in Swakopmund.
Innovative disinfection solution leaves no toxic residue
The disinfectant ANOSAN used in this process is produced by the blueplanet subsidiary ecabiotec AG. With the quantity provided, up to 77 million liters of water can be treated, hands disinfected, or public areas hygienically cleaned with the help of a nebulizer. The disinfection solution does not leave any toxic residues when used, as it decomposes into water and salt. It does not contain alcohol, aluminum oxides, dyes or fragrances and can be easily recycled. Viruses, bacteria, germs and fungal spores can thus be eliminated without posing a danger to humans, animals or the environment.
Increasing hygiene awareness and strengthening trust
Hepatitis E is often transmitted via contaminated drinking water and causes acute liver inflammation, which can be fatal, especially for pregnant women. In Namibia, particularly in the informal settlements on the suburbs, infections are currently increasing. Such outbreaks are favored by a lack of information and mistrust of the Namibian people towards hygiene standards. The wrong dosage of conventional disinfectants – with severe consequences – contributed to a lack of trust in hygiene. The ANOSAN provided by blueplanet Investments AG, on the other hand, cannot be overdosed and does not irritate the skin, eyes or mucosa. The company also contributes to hygiene education with appropriate information material and specially provided employees.
"We are fighting nationwide against the outbreak of hepatitis E," emphasizes Dr. Lilliane Kahuika, epidemiologist at the Namibian Ministry of Health. "The use of ANOSAN and the establishment of hygiene awareness can make a significant contribution to reducing the transmission rate of the virus and improving the situation in the affected areas. We can only thank blueplanet Investments AG for their support and commitment on site".
Long-term investment for a strengthened Namibia
The aim of blueplanet Investment AG is not only to support the Namibian people in the long-term fight against epidemics, but also to establish a sustainable system of humanitarian and economic aid in the country and to strengthen its economy. The company is therefore planning to set up its own national subsidiary and to distribute ANOSAN locally.
"The future of our planet is very important to us", explains Alexander Lattmann, CEO of blueplanet Investments AG. "When we heard about the spread of hepatitis in Namibia, we immediately knew that we wanted to help. If the population accepts the project well, we will extend our commitment to other areas. Our goal as a company is not only to be profitable, but also to do something good at the same time. To this end we are always looking for partners who share our views and want to see a real impact through their investments".